Advertisement
U.S. patients whose health insurance plans have high deductibles undergo fewer diagnostic imaging tests

Diagnostic Imaging Down With High Deductible Health Plans

0
Patients may not be equipped to discern which tests are medically necessary
A voting panel composed of patients with rheumatoid arthritis develops recommendations that are very similar to those of a physician-dominated panel when there is evidence warranting moderate or high confidence

Patient, Doctor Panels Develop Similar RA Recommendations

0
Panel composed of patients with RA develops same recommendations for 13 of 16 questions
Higher monthly doses of vitamin D have no benefit on lower extremity function and correlate with increased risk of falls compared with lower doses in elderly adults

High Dose of Vitamin D Tied to Higher Risk of Falls in Elderly

0
No benefit on lower extremity function and increased risk of falls for higher monthly doses
For patients with chronic conditions

Many Patients Using E-Mail As First Method of Provider Contact

0
Online communications reduced need for phone calls and office visits for many

December 2015 Briefing – Rheumatology

0
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for December 2015. This roundup includes the latest...
Physician burnout is the top issue for physicians in 2015

AMA: Burnout Is Top Issue for Physicians in 2015

0
More than half of docs report at least one symptom of burnout; efforts being undertaken to address burnout
Prices at hospitals in monopoly markets are 15 percent higher than those at hospitals in areas with at least four providers

Higher Hospital Prices in U.S. ‘Monopoly Markets’

0
Hospital prices positively associated with indicators of hospital market power
For patients with active ankylosing spondylitis

Secukinumab Cuts Symptoms of Ankylosing Spondylitis

0
Two trials show benefits for 150 mg subcutaneous secukinumab with IV, subcutaneous loading
Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.

FDA Approves Zurampic for the Treatment of Gout

0
Drug helps control blood levels of uric acid
For patients with hip and knee osteoarthritis

Combined Patient, Physician Intervention Ups Function in OA

0
Modest improvement in WOMAC, WOMAC function subscale for patients with hip, knee osteoarthritis